Lung Cancer (NSCLC)NCT07353489
easyEndoTM Powered in Thoracic Surgery
A study testing easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges in people with Lung Cancer (NSCLC), run by Ezisurg Medical Co. Ltd. at 1 site in China.
Trial summary
The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Lung Cancer (NSCLC)
- What is being tested?
- easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 61 participants
- Where
- 1 siteChina
- Study dates
- 20 Nov 2025to 1 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital.
- Surgery date was on or after January 1, 2024.
- Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information).
- Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data
Who cannot join
- Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery.
- Surgery date was before January 1, 2024.
- Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year).
- Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery).
- Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.
Trial locations and contacts
1 site in 1 country.
China1 site
Affiliated Hospital of Jining Medical University
Jining, Shandong, 272000
About this study
Official title: Evaluation of the Safety and Efficacy of Single Use Powered Endoscopic Staplers and Cartridges in Thoracic Surgery: A Retrospective Clinical Study
The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers
- Conditions
- Lung Cancer (NSCLC)
- Being tested
- easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges
- Medical subject headings
- Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
easyEndoTM Powered Single Use Powered Endoscopic Staplers and CartridgesDevice
Using easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges transection, resection, and/or creation of anastomoses in thoracic surgery
| Study group | Role | What they receive |
|---|---|---|
| easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges | Experimental | Not described Receives: Device: easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges |
What is being measured
The primary outcome is the main question the study is designed to answer.
stapling success rate
no leakage intra-operation and post-operation
Measured: Perioperative/Periprocedural
Secondary outcomes (8)
Intraoperative blood loss volume
Measured: Perioperative/Periprocedural
Blood transfusion requirement
Measured: Perioperative/Periprocedural
Conversion to open thoracotomy
Measured: Perioperative/Periprocedural
Length of hospital stay
Measured: Perioperative/Periprocedural
Postoperative drainage duration
Measured: Perioperative/Periprocedural
total drainage volume
Measured: Perioperative/Periprocedural
Reoperation requirement
Measured: Perioperative/Periprocedural
The incidence of complications
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jan 2026
- Study start20 Nov 2025
- Primary completion1 Jan 2026
- Study completion1 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung Cancer (NSCLC)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 61 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ezisurg Medical Co. Ltd.
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07353489
- Sponsor's protocol ID
- JN-Elite-01
- Status last verified
- Jan 2026
- First submitted
- 12 Jan 2026
- Last updated
- 20 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Safety and Efficacy of Single Use Powered Endoscopic Staplers and Cartridges in Thoracic Surgery: A Retrospective Clinical Study
- ClinicalTrials.gov ID
- NCT07353489
- Acronym / sponsor ID
- JN-Elite-01
- Conditions
- Lung Cancer (NSCLC)
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 61 participants (actual)
- Lead sponsor
- Ezisurg Medical Co. Ltd.University, hospital or other
- Study start
- 20 Nov 2025 (actual)
- Primary completion
- 1 Jan 2026 (actual)
- Study completion
- 1 Jan 2026 (actual)
- First posted
- 20 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges | Experimental | Device: easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (4 listed)
- Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital.
- Surgery date was on or after January 1, 2024.
- Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information).
- Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data
Key exclusion criteria (5 listed)
- Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery.
- Surgery date was before January 1, 2024.
- Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year).
- Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery).
- Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| easyEndoTM Powered Single Use Powered Endoscopic Staplers and CartridgesUsing easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges transection, resection, and/or creation of anastomoses in thoracic surgery | Device | easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges |
Primary outcome
stapling success rate
Time frame: Perioperative/Periprocedural
no leakage intra-operation and post-operation
8 secondary outcomes
Intraoperative blood loss volume
Time frame: Perioperative/Periprocedural
Blood transfusion requirement
Time frame: Perioperative/Periprocedural
Conversion to open thoracotomy
Time frame: Perioperative/Periprocedural
Length of hospital stay
Time frame: Perioperative/Periprocedural
Postoperative drainage duration
Time frame: Perioperative/Periprocedural
total drainage volume
Time frame: Perioperative/Periprocedural
Reoperation requirement
Time frame: Perioperative/Periprocedural
The incidence of complications
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Lung Cancer (NSCLC)
RecruitingPhase 1/2
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Advanced Solid Tumors, Metastatic Solid Tumors
RecruitingPhase 2
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
Nsclc, NSCLC Stage II
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
RecruitingPhase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
RecruitingPhase 3
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges in people with Lung Cancer (NSCLC), run by Ezisurg Medical Co. Ltd. at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
stapling success rate (time frame: Perioperative/Periprocedural). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2026.